Hydrogen peroxide (H2O2) is a reactive oxygen species (ROS) generated in the stereoselective deamination of D-amino acids catalyzed by o-amino acid oxidase (DAAO). H2O2 readily crosses cellular membranes and damages DNA, proteins, and lipids. The scarcity of DAAO substrates in mammalian organisms and its co-localization with catalase in the peroxisomal matrix suggested that the cytotoxicity of ROS could be harnessed by administration of o-amino acids to tumor cells ectopically expressing DAAO in the cytoplasm. To evaluate this hypothesis, the cDNA encoding the highly active DAAO from the red yeast Rhodotorula gracilis was mutated to remove the carboxy-terminal peroxisomal targeting sequence. A clonal line of 9L glioma cells stably transfected with this construct {9LdaaoYI) was found to synthesize active R. gracilis DAAO. Exposure of 9\-idaaoll cells to o-alanine resulted in cytotoxicity at concentrations that were nontoxic to parental 9L cells. Depletion of cellular glutathione further sensitized 9V.daaoVl cells to D-alanine (o-Ala). This result, combined with stimulation of pentose phosphate pathway activity and the production of extracellular H2O2 by 9L,daao\l cells incubated with D-alanine implicates oxidative stress as the mediator of cytotoxicity. These results demonstrate that expression of R. gracilis DAAO in tumor cells confers chemosensitivity to o-alanine that could be exploited as a novel cancer gene therapy paradigm.
OVERVIEW SUMMARY
Gene-directed enzyme prodrug therapy (GDEPT) is an antineoplastic treatment strategy designed to overcome the systemic toxicity of chemotherapy by specifically expressing a foreign enzyme in malignant cells that converts a nontoxic prodrug into a cytotoxic metabolite. The relative inefficiency of current in situ gene transfer methodology suggests that enzyme/prodrug combinations that produce membrane permeable metabolites will elicit a more favorable therapeutic response. Ideally, the agent produced by the transduced cell "factories" would be cytotoxic toward both proliferating and quiescent cells. We describe a novel GDEPT approach using D-amino acid oxidase from the red yeast Rhodotorula gracilis and D-alanine as a substrate that generates hydrogen peroxide, a reactive metabolite of oxygen that has both these characteristics. We also demonstrate INTRODUCTION SINGLE ELECTRON REDUCTIONS of molecular oxygen give rise to a series of toxic compounds. These reactive oxygen species (ROS) are generated by ionizing radiation, drugs, and environmental pollutants, as well as by normal metabolism. Hydrogen peroxide (H2O2) is a ROS produced in cells by oxidases and spontaneous or enzymatic superoxide anion dismutation. H2O2 readily crosses cellular membranes and is known to damage biopolymers, including DNA (Beckman and Ames, 1997; Henle and Linn, 1997) , proteins (Beriett and Stadhnan, 1997) , and lipids by direct oxidation or via ttansition metal-driven Haber-Weiss reduction to the exttemely reactive hydroxyl radDepartments of iBiological Chemistry and ^Radiology, University of Michigan, Ann Arbor, MI 48109. ^Department of Structural and Functional Biology, University of Milan, 21100 Varese, Italy.
ical (Halliwell and Gutteridge, 1989) . Recent evidence also indicates that H2O2 may induce apoptosis (Hockenbery et al, 1993; Kane et al, 1993; Johnson et al, 1996; Simizu et al, 1996; Bladier et al, 1997) .
Although the majority of interest in ROS has been directed to tiieir role in pathophysiology, it is appreciated that the cytotoxicity of ROS plays a mechanistic role in a number of antineoplastic therapies. The most widely employed of these modalities is radiation therapy, which produces hydroxyl radicals by direct radiolytic attack on water. ROS have also been implicated as cytotoxic mediators for a number of chemotherapeutic agents including bleomycin, doxorubicin, and others. Experimental tteatment modalities have been designed to produce ROS speciflcally in tumors. These range from photodynamic therapy (Halliwell and Gutteridge, 1989) to treatment of tumorbearing patients or animals with preformed H2O2 (Makino and Tanaka, 1953; Tumer, 1953; Green and Westtop, 1958; Sugara, 1958; Mealy, 1965) . Investigators have also employed the ROS-generating enzymes xanthine oxidase (XO) (Yoshikawa et al, 1995) and glucose oxidase (GO) as anti-cancer agents. Nathan and Cohn pioneered this approach in vivo when they demonsttated that GO conjugated to carboxylated latex microspheres prevented tumor cell growth in mice (Nathan and Cohn, 1981) . Liposome-encapsulated glucose oxidase has also been used to eradicate experimental plasmacytomas (Samoszuk et al, 1996) . Previously, we have demonsttated that inttatumoral H2O2 production following injection of polyethylene glycol (PEG)-stabilized GO into established subcutaneous rat 9L tumors resulted in a significant tumor growth delay (BenYoseph and Ross, 1994) . However, regulation of ROS production by exogenously administered GO in tumor-bearing hosts is problematic because the availability of its substtates, oxygen and glucose, cannot be significantiy modulated. In fact, the unregulated production of ROS by inttatumoral PEG-GO injections required administtation of antioxidants to minimize systemic toxicity. Similarly, although XO is a lower-activity enzyme than GO, its production of superoxide cannot be regulated in vivo because it is a promiscuous enzyme with a wide range of ubiquitous substrates (Massey, 1973) .
To overcome the limitations of GO and XO, we have proposed the use of D-amino acid oxidase (DAAO; EC 1.4.3.3) for cancer tteatment . DAAO catalyzes the stereoselective oxidative deamination of D-amino acids via the following reaction: D-amino acid -I-H2O -I-O2 ^ a-keto acid -I-NH3 -I-H2O2
The stereoselectivity oi Rhodotorula gracilis DAAO appears to be absolute; L-amino acids are neither substrates nor inhibitors of the R. gracilis enzyme (PoUegioni et al, 1992) . Although mammalian DAAO can oxidize glycine, the only achiral amino acid, glycine is a poor substtate for the DAAO homolog from the red yeast R. gracilis that required 300 mM glycine to observe any enzyme-monitored activity (PoUegioni et al, 1992) . Thus, production of ROS by R. gracilis DAAO in tumor cells could be regulated by exogenous administration of o-amino acids that are rare in mammalian organisms (Konno and Yasumura, 1992) . Moreover, R. gracilis can grow on D-Ala as a sole carbon and nitrogen source (Pilone et al, 1989) and its DAAO homolog is catalytically efficient. This isoform tightiy binds its FAD co-factor (Casalin et al, 1991) and has been reported to have a specific activity of 180 U/mg at 37°C with dAla substtate, as well as low substtate Kyi values (submillimolar for many D-amino acids) (PoUegioni et al, 1992) . In conttast, mammalian DAAO homologs are comparatively inactive. For example, the K^ for D-Ala is 6.5 mM for hog kidney DAAO, whereas the K^ for beef kidney enzyme is unmeasurable because it shows no activity, even at concenttations of D-Ala approaching its solubility limit of 1.2 Af (D'Aniello et al, 1993b; PoUegioni et al, 1993) .
Low levels of DAAO activity can be found in mammalian tissues (ranging from 0.81 to 780 mU/g wet tissue (Weimar and Neims, 1977; D'Aniello et al, 1993a) , however endogenous DAAO is localized to the peroxisomal matrix where high catalase activity can detoxify the H2O2 by-product. In fact, all known DAAO sequences contain type 1 peroxisomal targeting sequences (Faotto et al, 1995) . This co-localization of endogenous DAAO and catalase, along with its relatively low specific activity, is likely to account for the minimal toxicity of damino acids in mammals. This is evidenced by the fact that administration of high doses (2 grams/kg body weight) of dAla, a substtate of choice for R. gracilis DAAO, produced no histopathological changes in rat kidney proximal mbule cells, where the highest level of DAAO activity is found (Kaltenbach et al, 1979) .
The practical application of ROS-generating enzyme systems has also been hampered by difficulty in enzyme delivery. Advances in gene transfer technology offer the possibility of overcoming this shortcoming by inttoducing the cDNAs encoding enzymes into malignant cells. Such cancer gene therapy paradigms depend on expressing genes encoding nonmammalian enzymes that convert pharmacologically mert prodrugs to highly toxic metabolites. Rhodotorula gracilis DAAO is well suited to this delivery approach because unlike GO and XO, its constitutive expression is not anticipated to be cytotoxic due to the lack of endogenous substtates. Furthermore, H2O2 is relatively stable, membrane permeable, and is cytotoxic to both proliferating and quiescent cells. These characteristics are potential advantages over tiie cytotoxic agents produced by a number of other enzyme/prodrug combinations that have been designed for gene-directed enzyme prodrug therapy (GDEPT) protocols (Connors, 1995) .
In the present study, we investigated GDEPT using tiie R. gracilis DAAO cDNA. We have successfully expressed active R. gracilis DAAO lacking its carboxy-terminal peroxisomal targeting sequence in rat 9L gliosarcoma cells. Overexpression of cytoplasmically targeted DAAO in 9L tumor cells (Fig. l,Rxn. 1 ) conferred toxicity to D-Ala exposure. We have atttibuted this cytotoxicity to the induction of oxidative stress by overproduction of H2O2 leading to generation of hydroxyl radical (Fig. 1, Rxn. 2) by demonsttating that DAAO-expressing cells respond to D-Ala exposure by stimulating glucose flux through the pentose phosphate pathway (PPP), which is linked to glutathione peroxidase removal of H2O2 (Fig. 1 . Hydroxyl radical reacts with DNA, lipids, and protein, inducing cell death. Alternatively, H2O2 can be removed by catalase (catalase, Rxn. 3) in the peroxisomes or by glutathione peroxidase (GPx, Rxn. 4) in the cytosol or at the plasma membrane. The GSH consumed in the second reaction is regenerated by glutathione reductase (Rxn. 5), using NADPH produced by the oxidative branch of the PPP as reducing equivalents (Rxn. 6). GPx activity can be inhibited by depleting the de novo synthesis of GSH with lbutiiionine-(5,/f)-sulfoximine (BSO), a specific inhibitor of yglutamylcysteine synthetase (Rxn. 7).
GDEPT with an ROS-generating oxidase for the treatment of neoplastic disease.
MATERIALS AND METHODS
Plasmid construction The 1.2-kb Eco RI fragment from the plasmid pKK223.3-DAAO encoding the R. gracilis DAAO cDNA (GenBank U60066) (PoUegioni et al, 1997) was ligated into tiie polycloning site of the selectable eukaryotic expression vector PCDNA3.1"'" (Invittogen) to construct pcDAO. A high-fidelity PCR mutagenesis strategy employing a mixture of Pwo and Taq polymerases (Expand, Boehringer Mannheim) was used to insert a eukaryotic ttanslation initiation sequence (Kozak, 1989) and a unique Cla I site for screening. Two overlapping mutagenic oligonucleotides containing the Kozak sequence and Cla I site and two flanking oligonucleotides, one complementary to pcDNA3.1 and containing a unique Nde I site and the otiier complementary to a unique Sac U site in DAAO, were used to amplify 0.5-kb and 0.6-kb products. Aliquots from these separate reactions were combined in a subsequent PCR amplification to produce a 1.1-kb product that was digested with Nde I and Sac II and ligated in the sinularly digested template pcDAO. The resulting plasmids were screened for the mutation by digestion with Cla I. Mutagenesis was confmned and PCR amplification misincorporations were checked by automated sequencing (Biomedical Research Core Facilities, UMMC) of the plasmid pcKDAO. The carboxy-terminal Ser-Lys-Thr type-1 peroxisomal targeting sequence (PTS) of the DAAO insert was removed by mutating the TCG codon encoding the Ser to an amber stop codon with the Altered Sites II in vitro Mutagenesis System (Promega). Codon substitution was confirmed by automated sequencing and the mutagenized insert was recloned into the Eco RI site of pcDNA3.1 to make pcKDAOC. All mutants were also subcloned into bacterial expression vectors with native 5' untranslated sequence.
Cell culture, stable transfection, and cellular lysates Rat 9L gliosarcoma cells were cultured in minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, and antibiotics at 37°C in a humidified incubator with a 5% C02/95% air atmosphere. Cells were split by trypsinization once a week and were discarded after 30 passages. Exponentially growing cells were split 1:10 onto 10-cm tissue culture dishes the day before ttansfection with 30 /xg of pcKDAOC using the standard calcium phosphate precipitation method (Ausbel et al, 1994) . Stable ttansfectants were selected by growth in 0.5 mg/ml G418 and individual clones were isolated on trypsin-impregnated filter paper disks (Domann and Martinez, 1995) . Total cellular lysates were prepared by lifting adherent cells in 40 mM Tris, 1 mAf EDTA, 150 mAf NaCl pH 7.4 buffer. For Westem blotting, cell pellets were resuspended in 250 mM Tris pH 7.6 and lysed by brief sonication on ice. For enzyme assays, cell pellets were resuspended in 50 mM Na2H2P207 pH 8.3 and briefly sonicated. All exttact supernatants were clarified by two sequential microcentrifugation steps at 4°C.
Immunoblotting
Equal amounts of protein, as determined by the bicinchonini acid (BCA) protein assay (Pierce), were resolved by SDS/PAGE and transferted to nitrocellulose membranes (Laemmli, 1970; Towbin et al, 1979) . Immunodetection of DAAO was performed using affinity-purified rabbit polyclonal antibodies raised against purified R. gracilis DAAO holoenzyme (Perotti et al, 1991) . A peroxidase-conjugated goat-antirabbit immunoglobulin G (IgG) secondary antibody (Sigma) was used with 5-bromo-4-chloro-3-indolyl phosphate and nitto-blue-tettazolium chloride to visualize the antigen-antibody complex.
Enzyme and glutathione assays DAAO activity was measured with a horseradish peroxidase (HRP)-coupled, specttophotometric assay using o-dianisidine as a reducing chromogenic HRP substtate (Bemt and Bergmeyer, 1974) . Catalase (EC 1.11.1.6) activity was determmed by following the decrease in H2O2 absorbance in 240 nm at 37°C (Aebi, 1984) . The catalase reaction is a fu-st-order reaction in both enzyme and substtate, precluding the definition of an intemational catalase unit. In this study, one catalase unit is defined as the activity that will decompose 1 /nmole of H2O2 per minute at pH 7.0 and 37°C when the H2O2 concenttation falls from 10.3 to 9.2 mM. GPx (EC 1.11.1.9) activity was assayed by a glutathione reductase-coupled, specttophotometric assay of NADPH absorbance (Flohe and Gunzler, 1984) . Glucose-6-phosphate dehydrogenase (G6PDH, EC 1.1.1.49) activity was measured specttophotometrically as an increase in NADPH absorbance at 340 nm (Sigma Diagnostics Kit). Reduced glutathione levels were quantitated specttophotometrically using the GSH-400 assay (Bioxytech, Mame, France). AU assays were performed with Perkin-Elmer Lambda 6 or 14 specttophotometers. Protein quantitation was performed with the BCA assay. '3C2,6,6-2H2)glucose (Omicron Biochemicals, South Bend, IN) by glycolysis or the PPP produces different ratios of lactate isotopomers that are extruded into the medium and quantitated by selected ion-monitored gas chromatography/mass specttometry (GC/MS). Confluent ceUs in 24-weU culture plates were washed twice and incubated for 1 hr in KRB with 5.5 mM labeled glucose and varying concenttations of H2O2 or D-Ala. Triplicate wells were used for each experimental condition and samples from each well were analyzed in ttiplicate. PPP values were cortected for total lactate produced when increasing concenttations of H2O2 or D-Ala inhibited lactate production. PPP stimulation was expressed as the percentage of glucose above basal flux that was metabolized through the PPP relative to glycolysis to lactate.
Cytotoxicity assay
An automated microculture assay employing the proteinbinding dye sulforhodamine B (SRB, Sigma) was used to quantitate growth (Rubenstein et al, 1990; Ben-Yoseph and Ross, 1994) . Cells plated in 96-well culture plates at a density of 1,000-2,000 cells per well were allowed to grow for 24 hr, washed twice with Krebs-Ringer bicarbonate buffer (KRB), and exposed to increasing concenttations of H2O2 or d-or lAla in KRB. Following the exposure period of 1-24 hr, cells were gently washed twice and allowed to grow in MEM with FBS and antibiotics until untreated conttol wells reached subconfluence, generally after 4-7 days. The cells were then fixed and stained, and the absorbance at 540 nm was measured with an AutoReader microtiter plate reader (Cayman Chemicals). Toxicity was assessed as the fractional cell survival relative to unexposed conttols. At least 16 replicates of each experimental condition were performed. For BSO sensitization studies, cells plated in 96-well plates were cultured ovemight in MEM with semm, and subsequentiy incubated with 1 mM L-buthionine-(5./?)-sulfoximine (BSO) in MEM with semm for 24 hr prior to D-Ala exposure. IC50 values were calculated by nonlinear least-squares regression to a four-parameter logistic function using SigmaStat software (Jandel Scientific).
H2O2 assay
A modification of the phenol red oxidation assay (Pick and Keisari, 1980 ) was used to quantitate H2O2 release by cultured cells. Briefly, cells were grown to subconfluence in six-well plates, washed twice with KRB, and incubated with 1 ml of KRB containing phenol red, HRP, and increasing concenttations of dAla for 1 hr. The buffer was subsequentiy removed, aUcalmized with 1 A^^ NaOH, and clarified by centrifugation, and the absorbance of oxidized phenol red was measured at 610 nm. Standard curves were generated by addition of 100 X solutions of H2O2 in KRB to weUs without D-Ala. H2O2 production was expressed as nmol/hr per mg cellular protein. Under tiiese conditions tiie assay was linear over the 1-200 nmol/hr per mg range.
Pentose phosphate pathway flux
The method for determination of pentose phosphate pathway (PPP) activity has been previously described (Ben-Yoseph et al, 1994b; Ross et al, 1994) . Briefly, metabolism of (1,6-
RESULTS

Experiments with extracellular DAAO/o-Ala
Initial experiments were designed to examine the cytotoxicity of DAAO and D-Ala using purified enzyme. Exposure of 9L cells to increasing activities of purified Trigonopsis variabilis DAAO in the presence of enzyme-samrating concentrations of D-Ala revealed dose-dependent toxicity (IC50 of 0.5 mU/well). Toxicity was completely abrogated by the addition of excess bovine catalase (Fig. 2) , indicating that NH3, the other product of the DAAO reaction, does not significantly contribute to the observed cytotoxicity.
Expression of R. gracilis DAAO in 9L cells
The next series of experiments were designed to evaluate the feasibility of expressing cytoplasmicaUy targeted R. gracilis DAAO in mammalian cells. The R. gracilis DAAO cDNA was subcloned into the pcDNA3.1 expression vector under cytomegalovims (CMV) promoter/enhancer and mutagenized to inttoduce a consensus eukaryotic ttanslation initiation (Kozak) sequence upstream of the start codon. Introduction of tiie consensus Kozak sequence resulted in mutation of His2 to Asp to place a G in the -1-4 position, which immediately follows the start codon (Kozak, 1989) . A synonymous G-to-C point mutation in codon 102 encoding glycine was also produced during tiie polymerase chain reaction (PCR) mutagenesis. When expressed in Escherichia coli, the His2-Asp mutant had a specific activity in the cmde extract similar to the wild-type recombinant enzyme. Site-directed mutagenesis was also used to remove the carboxy-terminal type-1 peroxisomal targeting sequence (PTSl). The PTS 1-tmncated DAAO mutant was expressed in E. coh and purified to homogeneity (Campaner et al, 1998) . This mutant DAAO is also fully active, characterized by a specific activity on D-Ala of 103 U/mg protein at 25°C, an apparent K^ of 0.7 mM (125 U/mg protein and 0.83 mM, respectively, for the wild-type DAAO). The mutant also dimerized normally and bound its FAD co-enzyme with an affinity typical of the wild-type enzyme.
Stably transfected 9L ceUs were screened qualitatively for cytotoxicity induced by exposure to 5 mM D-Ala for 24 hr. A clone showing significant sensitivity to D-Ala, 9Ldaaol7, was chosen for further analysis. Immunoblotting of sonicated 9Ldaaon cell extracts with a polyclonal imti-R. gracilis DAAO antibody showed the presence of an approximately 40-kD protein in the transfected cells (Fig. 3, inset lane 3 ) that co-migrates with purified recombinant R. gracilis DAAO produced in E. coli (lane 1). Also present is an approximately 45-kD endogenous protein in parental 9L cells (lane 2) that is recognized by the polyclonal antibody, which serves as a convenient gelloading control. A peroxidase-coupled specttophotometric assay showed that DAAO activity in cmde 9lulaao\l cell extracts was 8.8 ± 0.3 U/100 mg protein (mean ± SE, « = 5), which cortesponds to approximately 0.06% of the soluble proteins, assuming wild-type DAAO specific activity. No DAAO activity was observable in untransfected 9L cells. Moreover, using oAla as a substtate, the DAAO expressed in 9Ldaaoll was found to have an apparent A'm of 1.1 mM (Fig. 3) . This value is in agreement with the measured K^ value for DAAO purified from R. gracilis cells and recombinant wild-type enzyme from E. coli (PoUegioni et al, 1992; Campaner et al, 1997) .
Antioxidant enzyme activities
Specttophotometric assays were employed to determine the activities of GPx and catalase, the two major H202-detoxifying enzymes in lysates of 9L^aaol7 cells (Fig. 1) . GPx activity was estimated to be 0.6 ± 0.1 U/100 mg cellular protein (mean ± SD, « = 3 separate cellular lysates). Catalase activity was estimated to be 150 ± 18 U/100 mg cellular protein (mean ± SD, n = 3 separate cellular lysates) with a starting H2O2 concenttation of 10.3 mM. Although G6PDH does not directiy detoxify H2O2, it is linked to the GPx-mediated decomposition of H2O2 via glutathione reductase and is the rate-determining step in NADPH production by the PPP (Fig. 1) . G6PDH activity in 9Ldaaoll extracts was determined to be 9.1 ± 2.1 U/100 mg protein (mean ± SD, n = 3 separate cellular lysates). creasing concentrations of D-Ala for 24 hr resulted in dose-dependent cytotoxicity with an IC50 of 2.6 ± 0.7 mM (mean ± SD, n = 12). Toxicity to parental 9L cells was minimal with significant cytotoxicity occurting only at hyperosmolar o-Ala concentrations (Fig. 4A) . Growth of 9L(iaaol7 was not inhibited by L-Ala (93% survival at 40 mM; data not shown). In addition, preincubation of 9Ldaaoll cells with 1 mM BSO for 24 hr caused a left shift in the dose-response curve (Fig. 4A) , resulting in a new IC50 of 0.4 ± 0.2 mM D-Ala (mean ± SD, n = 11). Specttophotometric assays revealed that BSO treatment depleted GSH levels in 9Ldaaon cells by 90 ± 17% (mean ± SD, n = 3). BSO did not enhance D-Ala cytotoxicity for 9L parental cells (data not shown). D-Alanine-induced cytotoxicity in 9Ldaao\l cells was also time-dependent (Fig. 4B) .
Oxidative stress
The phenol red oxidation assay was used to measure production of exttacellular H2O2 by cells cultured in the presence of D-Ala for 1 hr. 9Ldaao\l cells produced increasing amounts of H2O2 in response to increasing concenttations of D-Ala (Fig.  5 A) . Exttacellular concenttations of H2O2 began to increase significantly at D-Ala concenttations between 5 and 10 mM. In conttast, parental 9L cells did not produce H2O2 in the presence of D-Ala.
Stimulation of PPP activity was used as a metabolic indicator of H2O2 detoxification . When 9Ldaaoll cells were exposed to D-Ala for 1 hr, a dose-dependent stimulation of the PPP was observed with a maximal stimulation of 15.8 ± 1.5% above basal activity achieved between 10 and 20 mM D-Ala (Fig. 5B) . In conttast, D-Ala at concenttations as high as 40 mM did not elicit significant stimulation of glucose flux through the PPP in parental 9L cells ( Fig. 5B ; maximal stimulation 1.6 ± 0.5%). Moreover, expression of R. gracilis DAAO in 9Ldaaol7 cells did not significantiy affect the basal PPP activity (data not shown). Bolus addition of H2O2 also stimulated PPP glucose flux in 9lxlaaoll cells in a dose-dependent fashion, reaching a saturation level of 19.3 ± 1.5% above baseline at about 600 pM (Fig. 5C ), which is consistent with the maximal H202-induced stimulation of the PPP in parental 9L cells (Ben-Yoseph et al, 1994a) . It should also be noted that exttacellular addition of purified DAAO stimulated PPP activity in the presence of D-Ala to the same extent as preformed H2O2 (data not shown). Furthermore, this stimulation was completely blocked by inclusion of 4,000 units of catalase in the incubation buffer. 
DISCUSSION
A major problem in the clinical management of cancer patients is the limited differential toxicity of chemotherapeutic agents and radiation toward neoplastic versus normal cells. Gene ttansfer technology offers the possibility of surmounting tills limitation by inttoducing unique dmg targets into malignant cells. GDEPT paradigms for cancer gene therapy depend on expressing genes encoding nonmammalian enzymes that convert pharmacologically inert prodmgs to highly toxic metabolites. The studies reported here demonstrate the potential of inttacellular expression of R. gracilis DAAO together with administtation of D-Ala as a GDEPT protocol.
Prior to conducting ttansfection experiments, the cytotoxicity of purified DAAO against 9L ceUs was tested. In the presence of D-Ala, exttacellular DAAO was cytotoxic at low levels of activity and with brief periods of exposure (Fig. 2) . The IC50 was 0.5 mU/well, which over the 1-hr incubation period is calculated to produce 0.03 pmol of H2O2, cortesponding to a cumulative concenttation of 150 pM. This is consistent with the 60 pM IC50 for preformed H2O2 previously reported for 9L cells allowing for the difference between the bolus addition of preformed H2O2 versus its enzymatic production by exttacellular DAAO over 1 hr.
To produce cytoplasmic DAAO, the cDNA encoding R. gracilis DAAO was tmncated to remove its type-1 peroxisomal targeting sequence. The altered cDNA directed production of functional DAAO in both E. coli and 9Ldaaon cells, indicating that its peroxisomal targeting sequence is not requtted for enzymatic activity (Campaner et al, 1998) . SimUarly, expression of the mutant enzyme in 9hdaaoll cells did not significantly alter its apparent K^ for D-Ala using the cmde exttact (Fig. 3) . We attempted to confirm the cytoplasmic localization of the mutant DAAO in 9l.daaoll cells with immunofluorescence microscopy. DAAO appeared to be located in the cytoplasm (data not shown), however, definitive assignment of a cytoplasmic localization will require epitope-tagging of/?, gracilis DAAO because 9L cells contain an unidentified protein that cross-reacts with the affinity-purified rabbit antisera to the yeast homolog (Fig. 3, inset) . The observation that cytotoxicity occurs in 9hdaaoll cells despite the presence of 150 U/100 mg of catalase further implies cytosolic localization of DAAO. This is consistent with the ability of 8.8 U/100 mg of DAAO to overwhelm the detoxification capacity of 0.6 U/100 mg of GPx in the cytoplasm of 9Ldaaoll cells. The fact that the maximal stimulation of glucose flux through the PPP by D-Ala and performed H2O2 in 9hdaaoll cells was similar (Fig. 5B,C) further supports this interpretation. Additionally, extmsion of H2O2 from 9Ldaaon cells dramatically increased at concenttations of D-Ala between 5 and 10 mM (Fig. 5A ). This cortelates with the concenttation of D-Ala at which PPP stimulation was maximal (Fig. 5B) , indicating that GPx-mediated H2O2 removal was saturated. Thus, the intracellular half-life of H2O2 would be expected to be prolonged, providing a greater probability for its diffusion out of the cell. The presence of exttacellular H2O2 suggests that H2O2 produced by ttansduced cell "factories" should kill adjacent untransduced cells in a process known as "bystander" killing (Freeman et al., 1993) .
The toxic product of this therapeutic sttategy, H2O2, is toxic to both proliferating and quiescent cells (Vidair and Dewey, 1991) ; in conttast, the most commonly investigated GDEPT protocols generate cytotoxic agents that are specific for actively proliferating cells (Connors, 1995) . In support of the toxicity of H2O2 for nonproliferating cells, we have conducted qualitative experiments in which confluent 9Ldaaoll cells were exposed to 10 mM D-Ala ovemight. Under these conditions, the cells were kUled and detached from the culture plate (data not shown). The ability to kill noncycling cells is an attractive feature because a substantial fraction of cells within solid tumors may be quiescent (Yoshii etal, 1986) . Although H2O2 has been shown to induce programmed cell death in a number of cell types, apoptosis may not be the mechanism underlying the cytotoxicity of DAAO gene therapy due to the relatively large amounts of inttacellular peroxide generated. Further investigations are curtentiy underway to elucidate the mechanism of cell death.
In the context of primary CNS malignancies, we have previously shown that cultured glioma cells are intrinsically more susceptible to oxidative injury induced by H2O2 (IC50 = 60 juAf) than cultured primary neuronal (IC50 =100 pM) or astrocytic cells (IC50 = 600 pM) . A recent study also described an inverse cortelation between the histological grade and antioxidant enzyme activities in a series of human central nervous system (CNS) malignancies (Pu et al, 1996) . The authors of this study also reported that the mean GPx activity in 17 high-grade human gliomas was 1.1 ± 0.2 U/100 mg, which is comparable to the levels we observed in 9L cells. AdditionaUy, a wide artay of agents that interfere with cellular antioxidant repair mechanisms are avaUable. These include enzyme inhibitors, thiol-depleting dmgs, and DNA-repair inhibitors, all of which have been used as radiosensitizers. We previously reported that preincubation of 9L cells with BSO resulted in a three-fold sensitization to H202-induced toxicity (IC50 = 20 pM), thereby increasing their differential toxicity to H2O2 to five-and thirty-fold more than primary neuronal and asttocytic cultures, respectively Ben-Yoseph et al, 1994a) . SimUarly, the studies described herein showed that BSO further sensitizes 9Ldaaoll cells to dAla (Fig. 4A) . The ability to sensitize cells further to the DAAO gene therapy protocol with a wide variety of agents is unique among GDEPT sttategies and is particularly exciting for application to neuro-oncology because administtation of BSO to mice bearing intracranial gliomas resulted in a selective depletion of GSH in the tumors while normal brain GSH levels remained intact (Skapek et al, 1988) . This is especially promising because cellular glutathione content rather than antioxidant enzyme activities was the main predictor of the H2O2 sensitivity of six murine tumor models (Nathan et al, 1980) . The application of this negative selective system to in vivo cancer gene therapy awaits tiie results of a number of experiments. Most importantly, the pharmacokinetic properties of damino acids must be characterized to devise appropriate dosing schedules for evaluating the efficacy of the DAAO gene therapy approach in animal models. Eventually we hope that DAAO gene therapy will prove synergistic with multimodality brain tumor tteatment protocols including surgery, radiation, and chemotherapy. The fact that carmustine (BCNU), the mainline chemotherapeutic for malignant gliomas, is a potent and specific inhibitor of glutathione reductase and has been shown to sensitize tomor cells to H2O2 up to 18.7-fold (Nathan et al, 1980) supports this assertion.
In conclusion, this study demonsttated that the cytotoxicity of ROS can be harnessed by the expression of DAAO in tomor cells by gene ttansfer techniques. Exposure of tomor cells to dAla resulted in the cytotoxic overproduction of ROS. This novel gene therapy paradigm possesses several potential advantages over other GDEPT systems, (i) The H2O2 product is cell cycle nonspecific, (ii) H2O2 has similar cell permeability characteristics to water, thus providing the rationale for achieving bystander killing, (iii) Tumor cells can be presensitized to oxidative damage prior to tteatment with DAAO/o-Ala. (iv) The D-amino acid substtates for DAAO (e.g., D-Ala) are essentially nontoxic.
